Extract to table
Pull the structured facts out of a document: parties, dates, amounts, obligations.
Extract to table / regulatory-consent-tracker-memo.docx
regulatory-consent-tracker-memo.docx
Parties
Genome Dx Therapeutics Inc
Harkness LLP
Gregg LLP
Quelston Paige LLP
Towne Centre Properties LLC
Larkspur Corp
Ashgrove Partners LLC
Dates
August 9, 2023
May 11, 2023
August 8, 2023
August 1, 2023
May 14, 2023
December 31, 2022
May 18, 2023
June 17, 2023
June 22, 2023
September 12, 2019
Amounts
$140,000,000
$126,000,000
$14,000,000
$111.4
$445.5
$312,000,000
$589,000,000
$222.7
$22.3
$500
Obligations
Under the applicable size-of-person thresholds for 2023, one party must have total assets or annual net sales of at least $222
7 million, and the other party must have total assets or annual net sales of at least $22
3 of the Vantage License Agreement provides, in relevant part: "This Agreement and the rights and obligations hereunder may not be assigned or otherwise transferred by either party without the prior written consent of the other party, whether by operation of law or otherwise, and any purported assignment or transfer without such consent shall be null and void
1, which provides: "Tenant shall not assign this Lease or any interest herein, or sublet the Premises or any part thereof, or permit the use of the Premises by any party other than Tenant, without the prior written consent of Landlord, which consent shall not be unreasonably withheld, conditioned, or delayed
The sublandlord's consent is required, but the sublease provides that such consent "shall not be unreasonably withheld or delayed
Part 807, the owner or operator of a medical device establishment engaged in the manufacture, preparation, propagation, compounding, or processing of devices intended for commercial distribution in the United States must register the establishment with the FDA and list the devices manufactured or distributed by the establishment